Orthopedic Extremity Devices | Europe | 2018 | Market Analysis
The European orthopedic extremity device market will grow at a moderate pace through 2026, primarily as a result of favorable demographics, innovation in underpenetrated segments, an ongoing focus on surgeon training, and the uptake of premium-priced products. However, lingering economic uncertainty, cost constraints on hospitals, and the prevalence of alternative techniques will limit ASPs and revenue expansion over the forecast period.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for orthopedic extremity devices in Europe across a 10-year period.
Despite cost-containment efforts throughout Europe, some device segments will continue to drive revenue growth in the European orthopedic extremity device market.
Which device segments are relatively underpenetrated?
What are some of the innovative devices that have been launched in these segments?
What strategies are companies employing to increase their market shares in these segments?
Some technologies being launched in the orthopedic extremity device market have steep learning curves.
What strategies are companies using to increase the penetration of these technologies?
How can these technologies compete with established alternatives currently on the market?
The rising influence of GPOs and continued austerity measures in the European market have placed downward pressure on the pricing of orthopedic extremity devices.
Which device segments will face the greatest pricing pressures?
What should companies do to drive greater adoption of newer technologies in the face of such cost constraints?
